From Dr Eliot Forster, MedCity’s Executive Chair
Announcements over the past month testify to the increasing strength and reputation of the life sciences base of London and the greater south east. First up came the news that the number of new life sciences jobs in London created by international investment in our sector tripled in 2014 – a reflection of the fact that the diverse expertise of this region adds up to a businesses attractive whole.
That has been complemented by the decision of several well-regarded US health/life sciences firms to list on the London Stock Exchange; again, their choices are fuelled by a recognition of the variety of unique strengths that we are increasingly known for internationally.
Finally, huge congratulations to Keregen, winner of OneStart Europe 2015. Since setting up in 2013, OneStart has helped over 40 life sciences start-ups (mostly based in London, Oxford and Cambridge) raise funding of up to £3m – a huge achievement and an invaluable contribution to the UK’s life sciences ecosystem.